A History of Vitamin ENiki E.a · Traber M.G.b
aHealth Research Institute, AIST, Ikeda, Japan; bLinus Pauling Institute, Oregon State University, Corvallis, Oreg., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Vitamin E (α-tocopherol) was discovered nearly 100 years ago because it was required to prevent fetal resorption in pregnant, vitamin E-deficient rats fed lard-containing diets that were easily oxidizable. The human diet contains eight different vitamin E-related molecules synthesized by plants; despite the fact that all of these molecules are peroxyl radical scavengers, the human body prefers α-tocopherol. The biological activity of vitamin E is highly dependent upon regulatory mechanisms that serve to retain α-tocopherol and excrete the non-α-tocopherol forms. This preference is dependent upon the combination of the function of α-tocopherol transfer protein (α-TTP) to enrich the plasma with α-tocopherol and the metabolism of non-α-tocopherols. α-TTP is critical for human health because mutations in this protein lead to severe vitamin E deficiency characterized by neurologic abnormalities, especially ataxia and eventually death if vitamin E is not provided in large quantities to overcome the lack of α-TTP. α-Tocopherol serves as a peroxyl radical scavenger that protects polyunsaturated fatty acids in membranes and lipoproteins. Although specific pathways and specific molecular targets have been sought in a variety of studies, the most likely explanation as to why humans require vitamin E is that it is a fat-soluble antioxidant.
© 2012 S. Karger AG, Basel
- Evans HM, Bishop KS: On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922;56:650–651.
- Olcott HS, Mattill HA: The unsaponifiable lipids of lettuce: III. Antioxidant. J Biol Chem 1931;93:65–70.
Mattill HA: Antioxidants. Annu Rev Biochem 1947;16:177–192.
- Tappel AL: The inhibition of hematin-catalyzed oxidations by alpha-tocopherol. Arch Biochem Biophys 1953;47:223–225.
- Burton GW, Ingold KU: Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc Chem Res 1986;19:194–201.
- Niki E: Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 1987;44:227–253.
- Packer JE, Slater TF, Willson RL: Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737–738.
- Niki E, Noguchi N: Dynamics of antioxidant action of vitamin E. Acc Chem Res 2004;37:45–51.
- Bowry VW, Ingold KU, Stocker R: Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J 1992;288:341–344.
- Bowry VW, Mohr D, Cleary J, Stocker R: Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem 1995;270:5756–5763.
- Saito Y, Nishio K, Akazawa YO, Yamanaka K, Miyama A, Yoshida Y, Noguchi N, Niki E: Cytoprotective effect of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: tocopherols and tocotrienols exert similar effects by antioxidant function. Free Radic Biol Med 2010;49:1542–1549.
Gallo-Torres HE: Transport and metabolism; in Machlin LJ (ed): Vitamin E: A Comprehensive Treatise. New York, Marcel Dekker, 1980, pp 193–267.
- Liebler DC, Burr JA, Philips L, Ham AJ: Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products. Anal Biochem 1996;236:27–34.
- Murphy ME, Kolvenbach R, Aleksis M, Hansen R, Sies H: Antioxidant depletion in aortic crossclamping ischemia: increase of the plasma alpha-tocopheryl quinone/alpha-tocopherol ratio. Free Radic Biol Med 1992;13:95–100.
- Shi H, Noguchi N, Niki E: Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroquinone, ubiquinol, and alpha-tocopherol against lipid peroxidation. Free Radic Biol Med 1999;27:334–346.
- Atkinson J, Epand RF, Epand RM: Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med 2008;44:739–764.
- Evans HM, Emerson OH, Emerson GA: The isolation from wheat germ oil of an alcohol, alpha-tocopherol, having the properties of vitamin E. J Biol Chem 1936;113:319–332.
Emerson OH, Emerson GA, Mohammad A, Evans HM: The chemistry of vitamin E. Tocopherols from natural sources. J Biol Chem 1937;22:99–107.
- Machlin LJ, Gabriel E, Brin M: Biopotency of alpha-tocopherols as determined by curative myopathy bioassay in the rat. J Nutr 1982;112:1437–1440.
- Traber MG, Atkinson J: Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007;43:4–15.
- Cornwell DG, Williams MV, Wani AA, Wani G, Shen E, Jones KH: Mutagenicity of tocopheryl quinones: evolutionary advantage of selective accumulation of dietary alpha-tocopherol. Nutr Cancer 2002;43:111–118.
Machlin LJ: Vitamin E: A Comprehensive Treatise. New York, Marcel Dekker, 1980.
- Horwitt MK, Harvey CC, Duncan GD, Wilson WC: Effects of limited tocopherol intake in man with relationships to erythrocyte hemolysis and lipid oxidations. Am J Clin Nutr 1956;4:408–419.
- Binder HJ, Spiro HM: Tocopherol deficiency in man. Am J Clin Nutr 1967;20:594–603.
- Kayden HJ, Silber R, Kossmann CE: The role of vitamin E deficiency in the abnormal autohemolysis of acanthocytosis. Trans Assoc Am Physicians 1965;78:334–342.
- Stumpf DA, Sokol R, Bettis D, Neville H, Ringel S, Angelini C, Bell R: Friedreich’s disease: V. Variant form with vitamin E deficiency and normal fat absorption. Neurology 1987;37:68–74.
- Sokol RJ, Kayden HJ, Bettis DB, Traber MG, Neville H, Ringel S, Wilson WB, Stumpf DA: Isolated vitamin E deficiency in the absence of fat malabsorption – familial and sporadic cases: characterization and investigation of causes. J Lab Clin Med 1988;111:548–559.
- Nelson JS, Fitch CD, Fischer VW, Brown GO Jr, Chou AC: Progressive neuropathologic lesions in vitamin E deficient rhesus monkeys. J Neuropathol Exp Neurol 1981;40:166–185.
- Traber MG, Burton GW, Ingold KU, Kayden HJ: RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. J Lipid Res 1990;31:675–685.
- Traber MG, Burton GW, Hughes L, Ingold KU, Hidaka H, Malloy M, Kane J, Hyams J, Kayden JH: Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J Lipid Res 1992;33:1171–1182.
- Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, Kayden HJ: Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. J Clin Invest 1990;85:397–407.
- Traber MG, Sokol RJ, Kohlschütter A, Yokota T, Muller DP, Dufour R, Kayden JH: Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency. J Lipid Res 1993;34:201–210.
- Catignani GL, Bieri JG: Rat liver alpha-tocopherol binding protein. Biochim Biophys Acta 1977;497:349–357.
- Sato Y, Hagiwara K, Arai H, Inoue K: Purification and characterization of the alpha-tocopherol transfer protein from rat liver. FEBS Lett 1991;288:41–45.
- Sato Y, Arai H, Miyata A, Tokita S, Yamamoto K, Tanabe T, Inoue K: Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein. J Biol Chem 1993;268:17705–17710.
- Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K: Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 1997;409:105–108.
- Min KC, Kovall RA, Hendrickson WA: Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency. Proc Natl Acad Sci USA 2003;100:14713–14718.
- Yokota T, Igarashi K, Uchihara T, Jishage K, Tomita H, Inaba A, Li Y, Arita M, Suzuki H, Mizusawa H, Arai H: Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci USA 2001;98:15185–15190.
- Leonard SW, Terasawa Y, Farese RV Jr, Traber MG: Incorporation of deuterated RRR- or all-rac-alpha-tocopherol into plasma and tissues of alpha-tocopherol transfer protein-null mice. Am J Clin Nutr 2002;75:555–560.
- Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, Dib C, Gyapay G, Vignal A, Le Paslier D, Cohen D, et al: Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet 1993;5:195–200.
- Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel JL, Koenig M: Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 1995;9:141–145.
- Di Donato I, Bianchi S, Federico A: Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci 2010;31:511–515.
Schultz M, Leist M, Petrzika M, Gassmann B, Brigelius-Flohé R: Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? Am J Clin Nutr 1995;62(suppl):1527S–1534S.
- Sontag TJ, Parker RS: Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase. J Lipid Res 2007;48:1090–1098.
- Swanson JE, Ben RN, Burton GW, Parker RS: Urinary excretion of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans. J Lipid Res 1999;40:665–671.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.